miR‐132 mediates a metabolic shift in prostate cancer cells by targeting Glut1

Prostate cancer is the second leading cause of cancer‐related deaths among men worldwide. Early diagnosis increases survival rates in patients but the survival rate has remained relatively poor over the past years. Increasing evidence shows that altered metabolism is a critical hallmark in prostate...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Wei, Ding, Shi‐mei, Cao, Gang, Wang, She‐jiao, Zheng, Xiang‐hong, Li, Guo‐hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932453/
https://www.ncbi.nlm.nih.gov/pubmed/27398313
http://dx.doi.org/10.1002/2211-5463.12086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932453/
https://www.ncbi.nlm.nih.gov/pubmed/27398313
http://dx.doi.org/10.1002/2211-5463.12086

Ejemplares similares